HF
PEARW

HRT Financial’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

HRT Financial’s Portfolio PEARW Stock Details PEARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-16,778
Closed -$2K – 3765
2022
Q2 		$2K Sell
16,778
-1,333
-7% -$659 ﹤0.01% 2811
2022
Q1 		$14K Sell
18,111
-30,799
-63% -$21.6K ﹤0.01% 2873
2021
Q4 		$29K Buy
48,910
+30,799
+170% +$31.3K ﹤0.01% 2911
2021
Q3 		$17K Buy
+18,111
New +$18.9K ﹤0.01% 3159

Other funds holding PEARW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
SRF
Silver Rock Financial Los Angeles, California $49.7M AUM 17.42% 1-Year Est. Return

HRT Financial's PEARW Position: Q3 2022 in Review

HRT Financial sold out of Pear Therapeutics, Inc. Warrant (PEARW) in Q3 2022, closing a stake of 16,778 shares — an estimated $2K sold.

HRT Financial first reported a position in PEARW in Q3 2021 and held it in 4 quarters. The position peaked at $29K in Q4 2021. 36 funds tracked by Wall St. Rank hold PEARW as of Q3 2022.

  • HRT Financial reported no remaining Pear Therapeutics, Inc. Warrant position as of Q3 2022 after selling out during the quarter.
  • HRT Financial sold 16,778 Pear Therapeutics, Inc. Warrant shares in Q3 2022, an estimated $2K.
  • HRT Financial first reported a position in Pear Therapeutics, Inc. Warrant in Q3 2021 and held it in 4 quarters.
  • HRT Financial's Pear Therapeutics, Inc. Warrant position peaked at $29K in Q4 2021.
  • 36 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Warrant as of Q3 2022.

Based on HRT Financial's 13F filing for Q3 2022, filed 14 Nov 2022.